Nomura Holdings
PACB icon

Nomura Holdings’s Pacific Biosciences PACB Stock Holding History

Nomura Holdings’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-44,100
Closed -$216K – 2601
2014
Q3 		$216K Sell
44,100
-38,206
-46% -$200K ﹤0.01% 2373
2014
Q2 		$499K Sell
82,306
-15,416
-16% -$77.2K ﹤0.01% 1791
2014
Q1 		$519K Sell
97,722
-7,372
-7% -$46.6K ﹤0.01% 1768
2013
Q4 		$548K Sell
105,094
-874
-0.8% -$4.01K ﹤0.01% 1234
2013
Q3 		$584K Sell
105,968
-227,138
-68% -$788K ﹤0.01% 1320
2013
Q2 		$837K Buy
+333,106
New +$829K 0.01% 1055

Other funds holding PACB

MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
MMC
MDV Management Company Menlo Park, California $296M AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nomura Holdings's PACB Position: Q4 2014 in Review

Nomura Holdings sold out of Pacific Biosciences (PACB) in Q4 2014, closing a stake of 44,100 shares — an estimated $216K sold.

Nomura Holdings first reported a position in PACB in Q2 2013 and held it in 6 quarters. The position peaked at $837K in Q2 2013. 101 funds tracked by Wall St. Rank hold PACB as of Q4 2014.

  • Nomura Holdings reported no remaining Pacific Biosciences position as of Q4 2014 after selling out during the quarter.
  • Nomura Holdings sold 44,100 Pacific Biosciences shares in Q4 2014, an estimated $216K.
  • Nomura Holdings first reported a position in Pacific Biosciences in Q2 2013 and held it in 6 quarters.
  • Nomura Holdings's Pacific Biosciences position peaked at $837K in Q2 2013.
  • 101 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2014.

Based on Nomura Holdings's 13F filing for Q4 2014, filed 17 Feb 2015.